Brief: Algernon Provides Update On COVID-19 Phase 2B Final Study Data

Grey Matters Health

17/02/2021 14:42

Feb 17 (Reuters) - Algernon Pharmaceuticals Inc  AGN.CD :
    * ALGERNON PHARMACEUTICALS PROVIDES UPDATE ON COVID-19 PHASE
2B
FINAL STUDY DATA
    * ALGERNON PHARMACEUTICALS INC - REPORTS THAT DUE TO A FIRE
AT
ROMANIAN HOSPITAL SITE, THERE WAS A DELAY IN COMPLETING SITE
AUDIT AS PLANNED
    * ALGERNON PHARMACEUTICALS INC - SOURCE DATA AUDIT FROM ALL
SITES
AND FOR ALL PATIENTS IS NOW COMPLETE
    * ALGERNON PHARMA - SIGNIFICANT NUMBER OF PATIENTS IN STUDY
DID
RECEIVE SOME FORM OF AN IMAGING SCAN AS PART OF THEIR RELEASE
PROTOCOL FROM HOSPITAL

Source text for Eikon:  ID:nGNX3H82GD 
Further company coverage:  AGN.CD 

 ((Reuters.Briefs@thomsonreuters.com;))